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doi:10.1016/j.jtcvs.2006.10.004bjective: To analyze our experience with warm blood cardioplegia in pediatric
ardiac surgery.
ethods: We used intermittent (every 15 minutes after initial injection) warm blood
ardioplegia in the treatment of 1400 patients. Results were retrospectively com-
ared with those of 950 patients treated with cold blood cardioplegia. The following
arameters were analyzed: (1) hydric balance of cardioplegic solution; (2) resump-
ion of rhythm after aortic crossclamp removal; (3) duration of mechanical venti-
ation, intensive care unit stay, and incidence of mortality in 4 selected diagnostic
roups: ventricular septal defect, tetralogy of Fallot, atrioventricular septal defect,
nd transposition of the great arteries. These 4 groups, treated with warm or cold
ardioplegia, were comparable with regard to age, weight, crossclamp times, and
ercent with Down syndrome; (4) troponin level at 12 hours after aortic crossclamp-
ng; and (5) duration of intensive care unit stay for the 1400 patients.
esults: Warm versus cold cardioplegia: negligible fluid addition with warm car-
ioplegia compared with blood loss/prime dilution induced by cold cardioplegia;
pontaneous resumption of sinus rhythm in 99% versus 77% of patients (P  .001);
horter duration of ventilatory support in each diagnostic group, significant in all
ases; smaller increase in troponin in each group (P .05). Incidence of early death
as not different in the 2 groups. For the whole group, duration of the intensive care
nit stay was less than 48 hours in 86% versus 75% (P  .001).
onclusion: In our experience, normothermic cardioplegia has not generated any
articular inconvenience and its use was contemporary, with improved outcomes.
 
he advantages of warm cardioplegia were demonstrated as early as 1989 by
the Toronto group1 and confirmed later on.2,3 At present, this technique is
widely used in adult patients,4-6 whereas hypothermic cardioplegia remains
he standard method in pediatric patients.7 The purpose of this study was to describe
ur clinical experience with intermittent warm blood cardioplegia (IWBC) in
eonates, infants, and young children. The efficacy of this method of cardioplegia
as assessed by indirect biologic and clinical criteria.
atients and Methods
ince April 2001, we have combined IWBC with normothermic extracorporeal circulation.
he consent of the families was obtained in every case for this initial experience. The
ardioplegia circuit is similar to that used in adults (Figure 1). Oxygenated blood is taken
rom the oxygenator (diverted from the origin of the arterial line) and injected into a
ardioplegia cannula with an occlusive roller pump. The injection is either in the aortic root
r directly in the coronary artery ostium. A potassium-enriched solution is added to the blood
y means of an electrical syringe pump. This solution, first used at Broussais Hospital in
aris, is marketed under the name CP1B solution by Pharmacie Centrale des Hôpitaux de
aris, Assistance Publique. It has been used for more than 25 years as a cold crystalloid
ardioplegic solution and is composed of 0.8 mmol/mL potassium, 0.8 mmol/mL magnesium,
.45 mmol/mL chloride, and 0.05 mmol/mL procaine.
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DInitial infusion and reinjection rates are calculated according to
he patient’s body surface area (Table 1); the flow is equal to 1 to
.5 the physiologic coronary flow (estimated as 5% of the cardiac
utput). The initial injection is prolonged for 1 minute after elec-
rical arrest of the heart. Reinjections at two thirds of the initial
peed of injection are performed for 1 minute every 15 minutes
uring aortic crossclamping. The cardioplegic solution is aspirated
n the right atrium and returned to the cardiotomy reservoir.
This method has two main implications:
1. The addition of CP1B solution to the blood increases the
potassium concentration by 13.5 mEq per liter of solution;
the final potassium concentration in the solution is around
18 mEq/L.
2. The volume of CP1B is 60 times less than the volume of
blood (Table 1); for example, in a 3-kg baby, an initial
injection prolonged for 1.5 minutes is composed of 60 mL
of blood and 1 mL of CP1B, and for a 10-kg child, the
composition is 150 mL of blood and 2.5 mL of CP1B.
Abbreviations and Acronyms
CBC  cold blood cardioplegia
ICU  intensive care unit
IWBC  intermittent warm blood cardioplegia
PRIMACORP Prophylactic Intravenous Use of
Milrinone After Cardiac Operation in
Pediatrics
igure 1. Cardioplegic circuit. Rotor No. 1 is the arterial pump,
erforming the total bypass flow. Rotor No. 2 is the cardioplegia
ump, diverting the blood component of the warm blood car-
ioplegic solution. The syringe pump injects the potassium-rnriched solution (CP1B solution)
42 The Journal of Thoracic and Cardiovascular Surgery ● JanuResults of clinical use of IWBC were compared with those of
50 patients operated on with normothermic bypass and cold blood
ardioplegia (CBC). The composition of the CBC was one third of
lood withdrawn from the oxygenator and two thirds of potassium-
nriched crystalloid solution. The final potassium concentration
as influenced by the kalemia of blood in the oxygenator, the final
esult being about19 mEq/L. The two components were mixed in
plastic bag and cooled in iced water. They were injected by
imple gravity in small children; in older children, a positive
ressure generated about the plastic bag was necessary. The initial
njection was directly related to body surface area with the formula
00 mL/m2. Half the initial dose was reinjected every 20 to 30
inutes. The cardioplegic solution was most often aspirated from
he right atrium outside the bypass circuit. The volume of fluid loss
as equivalent to the blood withdrawn from the oxygenator; that
s, one third of the total volume of cardioplegic solution. In a 3-kg
aby, 35 mL of oxygenator blood was wasted during the initial
njection, and in a 10-kg child, 80 mL.
During the whole study, the surgical, anesthetic, perfusionist,
nd intensive care staff remained the same. Normothermic perfu-
ion was used in both groups. Ultrafiltration, during or after
ypass, was never used.
The peroperative and postoperative inotropic support was iden-
ical during the “cold” and “warm” periods. A phosphodiesterase
nhibitor, as proved by the PRIMACORP study,8 was used pro-
hylactically in patients at risk of low-output syndrome.
Several parameters were used to compare retrospectively the
ABLE 1. Nomogram: Flow rates of cardioplegic solution
nd body surface area
SA (m2) Flow rate (mL/min and mL/h)*
First injection Reinjection
0.18 30 20
0.2 40 30
0.25 50 30
0.3 60 40
0.35 70 40
0.4 80 50
0.5 100 70
0.6 120 80
0.7 140 90
0.8 150 100
0.9 170 110
1 190 120
1.1 210 130
1.2 220 140
1.3 240 160
1.4 260 170
1.5 280 190
1.6 300 200
SA, Body surface area. *The numeric value of a No. 2 roller pump flow
Figure 1, cardioplegia rotor) in milliliters per minute is equal to the numeric
alue of the cardioplegic solution syringe pump flow in milliliters per hour.esults obtained with the two techniques of cardioplegia.
ary 2007
R
S
I
n
n
c
d
m
s
p
w
a
t
fi
a
i
r
e
a
r
s
a
s
i
m
g
v
I
r
t
p
c
p
u
f
s
t
s
s
m
4
I
l
c
o
T
D
V
V
T
T
C
C
T
T
V
b ignifi
Durandy and Hulin Surgery for Congenital Heart Disease
CH
D● Hydric balance of the cardioplegic solution.
● Spontaneous resumption of electrical activity after release of
the aortic crossclamp.
● Time of ventilatory support, level of troponin I 12 hours
after aortic crossclamping, and length of intensive care unit
(ICU) stay were analyzed in 4 selected patient groups of
comparable age and weight (Table 2): in the IWBC group,
ventricular septal defect less than 6 months old, 148 patients;
tetralogy of Fallot less than 1 year old, 109 patients; atrio-
ventricular septal defect less than 6 months old, 53 patients;
and transposition of the great arteries in the neonatal period,
54 patients. In the CBC group numbers were respectively 75
ventricular septal defect, 76 tetralogy of Fallot, 55 atrioven-
tricular septal defect, and 49 transposition of the great ar-
teries.
● Length of stay in the ICU.
● Statistical analysis was performed by the Student t test for
comparison of means  SD and 2 test for comparison of
percentages.
esults
ince April 2001, 1400 patients were operated on with
WBC during aortic crossclamping. During this period, only
eonates with infradiaphragmatic total anomalous pulmo-
ary venous connection were treated with deep hypothermic
irculatory arrest, and they are not included in this study.
In the IWBC group, the total volume of infused car-
ioplegic solution ranged from 3 to 6 mL in neonates to 50
L in grown-up children of adult size. The cardioplegic
olution represented the only addition in volume to the
ump prime, as the sanguineous component of this solution
as constituted by blood diverted from the bypass circuit
nd returned to it.
In patients with CBC, hydric balance was variable: When
he cardioplegic solution was discarded from the operating
eld, blood was lost from the bypass circuit (the total
ABLE 2. Comparison of the 4 groups of patients
iagnosis No. of patients Mean age Mea
SD, CBC 75 3 1 mo 4
SD, IWBC 148 3 1 mo 4
NS
OF, CBC 76 5 2 mo 6
OF, IWBC 109 5 2 mo 6
NS
AVSD, CBC 55 4 3 mo 4
AVSD, IWBC 53 4 2 mo 4
NS
GA, CBC 49 7 2 days 3
GA, IWBC 54 6 3 days
NS
SD, Ventricular septal defect; TOF, tetralogy of Fallot; CAVSD, complete a
lood cardioplegia; IWBC, intermittent warm blood cardioplegia; NS, nonsmount lost was related to the number of cardioplegic p
The Journal of Thoracicnfusions); when the cardioplegic solution was inadvertently
ecuperated in the bypass circuit, dilution of the prime
nsued.
Results with IWBC, compared with those with CBC,
re depicted in Table 3. The proportion of spontaneous
esumption of sinus rhythm after aortic unclamping is
ignificantly better in IWBC patients. The delay between
ortic clamp removal and resumption of sinus rhythm is
hort, electrical activity appears most often during deair-
ng procedures, and sinus rhythm resumes within a few
inutes.
The comparison was extended to selected diagnostic
roups (Table 3) by evaluating the need for mechanical
entilation, the rise in troponin I level, and the length of
CU stay. Nonsurvivors and patients with extracardiac
easons for prolonged ventilation were excluded from
his analysis (Table 4). Causes of death were sepsis (4
atients), hemorrhage (3 patients), or incorrect surgical
ure: aortic insufficiency after arterial switch operation (1
atient) or massive mitral regurgitation after atrioventric-
lar septal defect repair (2 patients). Extracardiac reasons
or mechanical ventilation are severe pneumonia or re-
piratory syncytial virus infection with airway hypereac-
ivity (4 patients), diaphragmatic paralysis (2 patients), or
evere tracheal or subglottic stenosis confirmed by endo-
copic examination (3 patients). Average duration of
echanical ventilation was consistently lower within the
diagnostic groups in patients operated on with the aid of
WBC. Troponin modification was also consistently
ower and length of ICU stay was lower in patients with
omplete atrioventricular septal defect and transposition
f the great arteries.
Patients with IWBC generally had better hemodynamic
ght (kg) Aortic clamping time (min) Down syndrome (%)
0.9 28 7
0.8 26 8
NS
1.7 53 16
2.2 52 16
NS
0.9 75 19 58%
1.1 77 14 54%
NS NS
0.5 92 11
0.4 82  14
NS
ntricular septal defect; TGA, transposition of the great arteries; CBC, cold
cant.n wei
.5
.3
NS
.4 
.5
NS
.6
.5
NS
.3
3
NS
trioveerformance. In turn, this feature affected the duration of
and Cardiovascular Surgery ● Volume 133, Number 1 243
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DCU stay, which was significantly shorter for the whole
WBC group than for the CBC group (P  .001).
iscussion
o our knowledge, this is the first report indicating that
yocardial protection with IWBC in pediatric cardiac sur-
ery is safe and effective.
Continuous warm blood cardioplegia seems unrealistic
n pediatric surgery and is probably impossible in the repair
f some cardiac defects. Since efficiency and safety of
WBC have been demonstrated in adults,4-6 its application
ay be considered for pediatric surgery.
A warm solution is as efficient as a cold one in inducing
yperkalemic cardiac arrest. An advantage of IWBC is its
bsence of influence on hydric balance, the fluid volume
dded to the bypass circuit being negligible. On the con-
rary, a cold cardioplegic solution is composed of crystal-
oid mixed with blood from the oxygenator. The final he-
atocrit of the solution is around 10%, in the range
escribed as beneficial by experimental work.9 The car-
ioplegic solution is either discharged outside with blood
oss or aspirated in the cardiotomy reservoir, with increased
ABLE 3. Results
pontaneous sinus rhythm after aortic unclamping
ime to extubation, h, mean SD (min-max)
VSD
TOF
CAVSD
TGA
roponin I (mean SD)
VSD
TOF
CAVSD
TGA
CU stay (h)
VSD
TOF
CAVSD
TGA
CU stay  48 h
WBC, Intermittent warm blood cardioplegia; CBC, cold blood cardiopleg
trioventricular septal defect; TGA, transposition of the great arteries; ICU
ABLE 4. Patients excluded from the study
HD VSD CBC VSD IWBC TOF CBC TOF IWBC
ied % 0 [0] 1 (S) [0, 6] 1 (S) 1 0 [0]
CPMV 0 0 2 (DP, P) 3 (P, P, AS)
auses of death: S, sepsis; ISC, incorrect surgical cure; H, hemorrha
iaphragmatic paralysis, P, pneumoniae; AS, airway stenosis. CHD, Congen
trioventricular septal defect; TGA, transposition of the great arteries; CBC, co
44 The Journal of Thoracic and Cardiovascular Surgery ● Janurime dilution. The prime loss for each cardioplegic injec-
ion may require the addition of extra fluid in the bypass
ircuit, increasing blood consumption.
The adjunction of a cell salvage device is inefficient to
ounteract this side effect. The volume of each cardiople-
ic infusion is small and the delay to obtain the washed
oncentrated blood is too long to avoid extra fluid addi-
ion. The benefit of ultrafiltration is also questionable
ecause of the extra volume needed to prime the hemo-
lter circuit. Our rationale is to improve tolerance to
ardiopulmonary bypass by decreasing prime volume
olution. We use a prime (including priming of the car-
ioplegic circuit) of 140 mL for infants up to 5.5 kg and
f 170 mL for patients weighing between 5.6 and 13 kg.
o achieve this small volume, we eliminated every com-
onent that is not absolutely mandatory, such as the
ltrafiltration circuit. During hypothermic perfusion, he-
odilution is frequently used; on the contrary, normo-
hermic perfusion is commonly performed with normal
ematocrit values, so there is hardly any need to
emoconcentrate the patient. In any case, the absence of
IWBC CBC P value
99 % 77 % P  .001
8 (3-48) 13 10 (4-48) P  .01
6 (2-180) 14 17 (3-120) P  .008
70 (5-260) 85 127 (12-250) P  .03
29 (6-150) 83 105 (10-192) P  .01
7 14  8 P  .019
7 19  9 P  .009
9 30  10 P  .005
6 16  7 P  .03
13 40  12 P  .53
15 45  13 P  .23
76 99  92 P  .03
28 101 102 P  .03
86% 75% P  .001
SD, ventricular septal defect; TOF, tetralogy of Fallot; CAVSD, complete
nsive care unit.
AVSD CBC AVSD IWBC TGA CBC TGA IWBC
1 (ISC) [2] 1 (ISC) [2] 3 (H, ISC, S) [6] 3 (H, H, S) [5]
1 (AS) 2 (P, AS) 1 (DP) 0
CPMV, Extracardiac reason for prolonged mechanical ventilation; DP,
eart defect; VSD, ventricular septal defect; TOF, tetralogy of Fallot; AVSD,9
8
38
41
11
13
23
12
38
41
56
65
ia; Vge; E
ital hld blood cardioplegia; IWBC, intermittent warm blood cardioplegia.
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Dide effect on fluid balance of IWBC allows a simpler
ypass procedure.
The main limitation of this study is its retrospective
ature. However, we believe that there are some arguments
o its validity:
● The number of patients studied is large (1400) in a
5-year period. During this period there were no major
changes in the staff or in the management of patients.
● The resumption of sinus rhythm after aortic unclamp-
ing in nearly all patients has been described in adult
patients as well, operated on with warm cardiople-
gia.4-10 The myocardial protection is critical in neo-
nates, deeply cyanotic infants,11 and those with pro-
longed aortic crossclamping times. In our analysis, we
have chosen 4 groups of patients who may represent
increasing need of myocardial protection. These
groups were composed by patients as similar as pos-
sible. Patients with associated malformations were
excluded. Age limits were adapted to avoid clinical
dissimilarities.
Time to extubation is not a direct effect of myocardial
rotection but is used as an index of quality of cardiople-
ia.11-13 Spontaneous breathing is an important stage in the
ostoperative period, which implies adequate hemodynamic
nd gas exchange. We have excluded from the analysis
atients with an extracardiac reason for prolonged ventila-
ion as well as nonsurvivors. The number of excluded pa-
ients is low and similar in each group.
Mortality is equivalent with the 2 techniques of cardio-
legia; death followed imperfect surgical repair (3 cases),
emorrhage (3 cases ), and sepsis (4 cases). Similar events
re most unlikely related to cardioplegia.
Furthermore, the inclusion of time to ventilation of non-
urviving patients is open to criticism inasmuch as 50% of
atients died within 12 hours.
The modification of troponin level is used to evaluate the
uality of myocardial protection, but it may also be influ-
nced by the type of cardiac defect.12-16 The rise in troponin
evel is more important in pediatric than in adult patients,
nd the widest variations are described after surgery for
omplete atrioventricular septal defect, tetralogy of Fallot,
nd homograft or xenograft implantation.17 For this reason,
onsensus is lacking on the value of the median or peak
evel after pediatric surgery: around 4 to 7 ng/mL after
rterial switch18 or 25 ng/mL as a cutoff point for the
efinition of a high- and a low-risk group.19 Our data are in
oncordance with the literature: the higher levels of post-
perative troponin I are found in complete atrioventricular
eptal defect and tetralogy of Fallot. Troponin increase is
ignificantly lower in the 4 groups treated with IWBC than
n those treated with CBC. Time to extubation is lower in
atients with ventricular septal defect and tetralogy of Fal-
The Journal of Thoracicot. The difference is significant but too short to modify
ength of ICU stay. On the contrary, time to extubation and
CU stay are significantly shorter for patients with complete
trioventricular septal defect and those with transposition of
he great arteries.
ICU stay is shorter with IWBC than with CBC. In our
ractice, IWBC is associated with improved hemodynamic
tability, allowing early extubation in the majority of cases.
esumption of feeding commonly starts in the first 12 hours
fter the operation, and duration of inotropic support rarely
xceeds 48 hours.
The percentage of patients who require postoperative
notropic support is also considered as a relevant factor in
valuating the efficacy of myocardial protection.11,17,20
hese data were not analyzed in this study. Enoximone was
sed prophylactically in neonates and infants at risk of low
ardiac output syndrome along with the PRIMACORP
tudy, which showed a 64% relative risk reduction in the
evelopment of low cardiac output syndrome with the pro-
hylactic use of a similar drug, milrinone.8 An identical
rophylactic treatment has been used in the 2 groups of
atients compared in this study; that is, before weaning from
ypass, all the patients within the 4 groups studied received
loading dose of enoximone, 1 mg/kg in 15 minutes fol-
owed by a continuous infusion of 10 g · kg1 · min1.
onclusions
uality of cardiac surgery outcome cannot be attributed to
ny single element in the procedure. This analysis of a large
roup of patients treated over a 5-year period allowed us to
how that pediatric cardiac surgery with normothermic
yocardial protection is a valid alternative to cold cardio-
legia. This preliminary work should be validated by pro-
pective studies.
We thank Duccio Di Carlo, MD, for his critical review of this
ork and Françoise Zerah Lancner, MD, for statistical expertise.
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